The Efficacy of Intravesical Tice Strain Bacillus Calmette-Guerin in the Treatment of Interstitial Cystitis: A Double-Blind, Prospective, Placebo Controlled Trial
Authors:
- 1 June 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 157 (6) , 2090-2094
Abstract
Interstitial cystitis is a debilitating bladder disease of unknown etiology with no cure. A recent report suggested that bacillus Calmette-Guerin (BCG) may be effective in the treatment of interstitial cystitis. A randomized, prospective, double-blind, placebo controlled trial to evaluate the safety and efficacy of intravesical BCG in treating interstitial cystitis was done. Patients meeting the National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases criteria for interstitial cystitis received 6 weekly instillations of Tice strain BCG or placebo. Periodic questionnaires, voiding diaries and cystometrograms were obtained. A total of 30 evaluable subjects was enrolled in the study with a mean followup of 8 months (range 6 to 13). Based on an exit questionnaire a responder was defined as one who rated the interstitial cystitis symptoms as moderately improved or better. A 60% BCG response rate was noted, compared to a 27% placebo response rate. Minimum voided volume and quality of life improved in the BCG group compared to placebo. Adverse events were similar in each group, mostly irritative in nature, and no significant systemic events were noted. Intravesical Tice strain BCG appears to be safe and efficacious in the treatment of interstitial cystitis. Additional studies must be performed to confirm the results of this pilot study.Keywords
This publication has 12 references indexed in Scilit:
- MEASUREMENT OF SYMPTOMS OF INTERSTITIAL CYSTITISUrologic Clinics of North America, 1994
- Bacillus Calmette-Guérin immunotherapy for refractory interstitial cystitisUrology, 1994
- A Quantitatively Controlled Method to Study Prospectively Interstitial Cystitis and Demonstrate the Efficacy of PentosanpolysulfateJournal of Urology, 1993
- Evidence for Urothelial Cell Activation in Interstitial CystitisJournal of Urology, 1993
- Abnormal urothelial HLA-DR expression in interstitial cystitisClinical and Experimental Immunology, 1992
- Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987Journal of Urology, 1988
- Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.Journal of Clinical Pathology, 1987
- Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.Journal of Experimental Medicine, 1986
- ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITYThe Lancet, 1983
- A Rare Type of Bladder Ulcer in Women; Report of CasesNew England Journal of Medicine, 1915